APEX1 and non-small cell lung carcinoma: A recent clinical trial (ClinicalTrials.gov (accessed on 4 April 2023) Identifier: NCT00540722) aimed to investigate the potential clinical benefit of combining Gossypol with docetaxel and cisplatin in patients with NSCLC who have high expression of APE1 [193].